School-Age Neurodevelopmental and Atopy Outcomes in Extremely Preterm Infants: Follow-Up from the Single Versus Triple-Strain Bifidobacterium Randomized Controlled Trial.
- 2026-01-01
- RCT
- Nutrients 18(1)
- Gayatri Athalye-Jape
- Chandra Rath
- Meera Esvaran
- Angela Jacques
- Sanjay Patole
- PubMed: 41515257
- DOI: 10.3390/nu18010141
- High evidence
- Rigorous Journal
neurodevelopmental outcomes [severe impairment (FSIQ < 70): SS: 7.4% versus TS: 4.3%; p = 0.68], growth, BMI, and BP were comparable between the SS and TS groups.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- not stated in abstract